Analyst Upgrades: Advanced Micro Devices, Inc., NVIDIA Corporation, and Conatus Pharmaceuticals Inc

Analysts upwardly revised their ratings and price targets on Advanced Micro Devices, Inc. (AMD), NVIDIA Corporation (NVDA), and Conatus Pharmaceuticals Inc (CNAT)

Dec 20, 2016 at 9:13 AM
facebook X logo linkedin


Analysts are weighing in on semiconductor stocks Advanced Micro Devices, Inc. (NASDAQ:AMD) and NVIDIA Corporation (NASDAQ:NVDA), as well as biotech issue Conatus Pharmaceuticals Inc (NASDAQ:CNAT). Here's a quick roundup of today's bullish brokerage notes on AMD, NVDA, and CNAT.

  • AMD is up 2.3% ahead of the bell, and on pace to make another run at nine-year highs, after Mizuho raised its rating on the stock to "buy" from "neutral," saying, "AMD is a name we missed," and citing growth in the artificial intelligence (AI) industry. It's been an incredible year so far for Advances Micro Devices, Inc., which has tacked on a cool 281.5% in 2016, at $10.95. However, near-term options traders have taken an unusually put-heavy approach to the stock. Specifically, AMD's Schaeffer's put/call open interest ratio (SOIR) of 0.94 sits in the high 82nd percentile of its annual range.

  • Mizuho also weighed in on NVDA, raising its price target to $115 from $80. What's more, Goldman Sachs added NVIDIA Corporation to its "Conviction Buy" list, and increased its price target on the stock to $129 from $92 -- uncharted territory. The shares are up 3.1% in pre-market trading as a result, and set to open at a new record high. The stock has been shooting sharply higher, more than tripling in value over the last 12 months, at $101.63. But that doesn't mean the equity's rally is out of fuel. In fact, nearly 14% of NVDA's available float is wrapped up in short interest, representing more than a week's worth trading, based on average daily volumes. That's plenty of buying power waiting on the sidelines to drive the shares to higher highs.

  • CNAT announced last night it has entered into a licensing agreement with Novartis AG (ADR) (NYSE:NVS) to develop a fatty liver disease treatment, sending the shares soaring more than 150% in electronic trading. After closing Monday at $1.96 -- off 32% year-to-date -- Conatus Pharmaceuticals Inc is on track to open at a level not seen since September 2015, blowing past resistance at the 40-week moving average. The news also inspired no fewer than four brokerage firms to raise their price targets on CNAT, including H.C. Wainwright, which doubled its target to $18 -- a roughly 15% premium over the stock's January 2014 record high, and 818% above last night's finish. Likewise, in addition to raising its target price to $10 from $6, JMP Securities explained, "If successful, we see a multibillion-dollar product with significant upside for investors." Analysts were already in the security's bullish corner prior to the licensing deal, with all six firms following CNAT maintaining a rating equivalent to a "strong buy."
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI